📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Select Immunogenomics

1.1 - Company Overview

Select Immunogenomics Logo

Select Immunogenomics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of data analysis, predictive modeling, and reporting in support of genomic studies.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Select Immunogenomics

DNAfit Logo

DNAfit

HQ: United Kingdom Website
  • Description: Provider of at-home DNA testing and genetic insights for health, fitness, and nutrition. Offerings include CircleDNA Premium (500+ reports via saliva swab), genetic carrier screening, disease and cancer risk overviews, diet and fitness reports, skin predisposition insights, and success trait summaries to help personalize exercise, nutrition, and skincare choices.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full DNAfit company profile →
NAT Diagnostics Logo

NAT Diagnostics

HQ: United States Website
  • Description: Provider of a molecular diagnostic platform for true point-of-care infectious disease testing in physician offices, clinics, pharmacies, and other sites where patients are seen by medical personnel, delivering highly accurate results to improve the diagnostic experience.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NAT Diagnostics company profile →
RNAissance Ag Logo

RNAissance Ag

HQ: United States Website
  • Description: Provider of ribonucleic acid and RNAi products, offering innovative technology for large-scale fermentation-based production of exogenous RNAi, addressing mass production challenges and enabling farmers to protect and improve crops and cattle.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full RNAissance Ag company profile →
MyoNexus Therapeutics Logo

MyoNexus Therapeutics

HQ: United States Website
  • Description: Provider of clinical-stage gene therapies for limb-girdle muscular dystrophy (LGMD) types 2D, 2B, 2E, 2L, and 2C based on research at Nationwide Children’s Hospital; RNA exon-skipping technologies for rare diseases, particularly Duchenne muscular dystrophy, using PMO with next-generation PPMO in development; gene editing research; and precision genetic medicine platforms for Charcot-Marie-Tooth disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MyoNexus Therapeutics company profile →
Lynx Therapeutics Logo

Lynx Therapeutics

HQ: United States Website
  • Description: Provider of biotechnology diagnostic and therapeutic solutions, including Lynxgen Therapeutics LongSAGE mRNA for mRNA sequence analysis to support precision treatment and diagnostics; globally distributed ELISA kits for detecting biomarkers such as chemokines and COVID-19; and exosome-based methods for diagnostics and therapy addressing antibiotic resistance in Mycoplasma pneumoniae.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Lynx Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Select Immunogenomics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Select Immunogenomics

2.2 - Growth funds investing in similar companies to Select Immunogenomics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Select Immunogenomics

4.2 - Public trading comparable groups for Select Immunogenomics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Select Immunogenomics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Select Immunogenomics

What does Select Immunogenomics do?

Select Immunogenomics is a provider of data analysis, predictive modeling, and reporting in support of genomic studies.

Who are Select Immunogenomics's competitors?

Select Immunogenomics's competitors and similar companies include DNAfit, NAT Diagnostics, RNAissance Ag, MyoNexus Therapeutics, and Lynx Therapeutics.

Where is Select Immunogenomics headquartered?

Select Immunogenomics is headquartered in United States.

How many employees does Select Immunogenomics have?

Select Immunogenomics has 1,000 employees 🔒.

When was Select Immunogenomics founded?

Select Immunogenomics was founded in 2010 🔒.

What sector and industry vertical is Select Immunogenomics in?

Select Immunogenomics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Select Immunogenomics

Who are the top strategic acquirers in Select Immunogenomics's sector and industry

Top strategic M&A buyers and acquirers in Select Immunogenomics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Select Immunogenomics?

Top strategic M&A buyers groups and sectors for Select Immunogenomics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Select Immunogenomics's sector and industry vertical

Which are the top PE firms investing in Select Immunogenomics's sector and industry vertical?

Top PE firms investing in Select Immunogenomics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Select Immunogenomics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Select Immunogenomics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Select Immunogenomics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Select Immunogenomics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Select Immunogenomics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Select Immunogenomics?

The key public trading comparables and valuation benchmarks for Select Immunogenomics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Select Immunogenomics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Select Immunogenomics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Select Immunogenomics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Select Immunogenomics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Select Immunogenomics's' sector and industry vertical?

Access recent funding rounds and capital raises in Select Immunogenomics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Select Immunogenomics

Launch login modal Launch register modal